行情

ARAY

ARAY

精确射线公司
NASDAQ

实时行情|Nasdaq Last Sale

3.280
-0.150
-4.37%
盘后: 3.280 0 0.00% 16:30 01/17 EST
开盘
3.480
昨收
3.430
最高
3.590
最低
3.250
成交量
82.70万
成交额
--
52周最高
5.40
52周最低
2.350
市值
2.92亿
市盈率(TTM)
-17.4561
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ARAY 新闻

  • Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020
  • PR Newswire.3天前
  • Accuray Releases Materials For Jan. 15 Presentation At JP Morgan Healthcare Conference; Sees FY2021 Revenue CAGR 8%-12%
  • Benzinga.6天前
  • Accuray To Discuss Revenue Growth Expectations for the Next Three Fiscal Years at the JP Morgan Healthcare Conference
  • PR Newswire.6天前
  • Better Buy: Intuitive Surgical vs. Accuray
  • MotleyFool.com.01/09 12:30

更多

所属板块

先进医疗设备和技术
+0.57%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

ARAY 简况

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
展开

Webull提供Accuray Incorporated的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。